We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
Wearable technologies are making a massive impact on society, beginning to blur the boundary between human and machine. It is also an exploding commercial market set to be worth $12.6 billion by 2018.
The next generation of lightweight, high performance machines will rely on technologies that are capable of bringing the user as close to a device as possible.
Peiman has created the first reported nano-display device that uses both optical and electronic property modulation in Phase Change Materials. Peiman’s company, Bodle Technologies, spun out of Oxford University in November 2015, to further advance this technology.
An entirely new class of ultra-thin, ultra-high resolution displays with nanosecond access speed and no power consumption in static mode is now under development by his team.
This revolutionary display will initially target the rapidly growing microdisplay market compact, projection based displays used in emerging near-eye applications like Google Glass. The first prototypes are currently under development, with a small working device set to be ready within the next 12 months.
Chief Product Officer, Mirada Medical Ltd
Mirada Medical uses deep learning technology to develop medical imaging software that improves treatment and care for patients with cancer and other diseases. Its software automates tasks and processes in a range of clinical work, including diagnostic imaging, radiation therapy and interventional oncology, thereby helping to optimise workflows, save time and improve consistency.
The company has developed a range of accessible solutions that easily fit within existing platforms and technologies. Mirada Medical’s products have been installed in over 2,000 hospitals, imaging centres and cancer centres worldwide, supporting clinicians to make better decisions and deliver personalised care. One of its products, developed to optimise treatment for patients undergoing radiotherapy, offers significant time savings when compared to similar technologies.
As Chief Product Officer, Sarah Bond aims to strategically increase revenue and market share through the development of innovative products that will help the company to retain its competitive advantage.
Supported by the SME Leaders Programme, Sarah Bond will have access to workshops, training, mentoring and networking opportunities to help strengthen the skills needed to lead a talented, growing team. This will help her to deliver a complex and ambitious business plan for growth in the rapidly evolving market of artificial intelligence for healthcare.
Visit Mirada's website here.
CTO, Humanising Autonomy
Humanising Autonomy develops software solutions targeting the human-centred implementation of autonomous technology in the road safety sector. The company combines expertise in artificial intelligence (AI) and behavioural psychology to better understand the range of complex human behaviours. It uses this knowledge to predict the actions of vulnerable road users such as cyclists and pedestrians, so that autonomous systems can operate with greater safety.
Estimates suggest a two second warning could help prevent up to 90% of all collisions between vehicles and hazards that may lie ahead of them. Humanising Autonomy is building a large, diverse and global data set of human behaviours that takes into account culture and context. Using novel approaches in AI, this data will be used to deliver real-time predictions for different automated driving systems to make roads safer.
In 2019, the start-up partnered with Arriva London and Transport for London to develop new software for driver-assistance systems to improve safety.
Raunaq Bose, CTO, leads the development of Humanising Autonomy’s core technologies. With support from the SME Leaders Programme, his mission is to manage R&D in a responsive way that integrates the company’s goals with the needs of external customers and investors. Structured learning through the programme will help Raunaq Bose to strengthen his leadership skills as the company looks to integrate its technology into real vehicles in urban environments and laying the foundations for deploying its software more widely.
Visit Humanising Autonomy's website here.
CEO, SurePulse Medical Limited
Technologies developed at SurePulse help advance the care of newborns by providing easier access to relevant data. This helps make better clinical decisions in time-critical situations.
Around 10% of babies need some form of stabilisation and resuscitation at birth, equating to around 500,000 babies born in Europe each year. Heart rate is the best indicator of resuscitation success but current methods for heart rate monitoring, such as stethoscopes, can lead to delays and errors. SurePulse Medical’s first product, the SurePulse VS, is a vital sign monitoring system that improves clinicians’ ability to make timely decisions about care pathways. Launched in Europe in 2019, the SurePulse VS is designed for comfort and ease-of-use with sensors embedded in a cap for the baby that provides continuous, accurate vital sign data.
Dr James Carpenter, CEO, has successfully led the company through the early development of the technology and clinical trials. Support from the SME Leaders Programme comes at a pivotal stage as SurePulse transitions from a focus on technology development to one seeking commercial sales and growth.
Dr Carpenter aims to leverage opportunities through the programme to support him with product commercialisation, to help lead a talented, self-driven team and prioritise options that match the needs of a rapidly growing business.
Visit SurePulse Medical's website here.
CEO and Co-founder, Aceleron
Lithium batteries are often discarded with up to 80% of life left. The way they are manufactured limits their capacity for being repurposed. Aceleron aims to change this by delivering services and manufacturing a range of lithium batteries that are easier to repair and recycle using non-permanent assembly methods.
Aceleron’s patented technology makes energy storage more likely by promoting re-use and re-manufacture rather than disposal, leading to reduced lifetime costs. Its circular economy solutions are designed for ease of use at home and in commercial systems. They can also be used for solar energy storage.
Batteries made by Aceleron are lightweight yet robust enough to endure harsh environments, providing an accessible source of energy wherever needed. Current products include residential energy systems for use in places such as the Caribbean that enable efficient energy storage with improved resilience to natural disasters.
Dr Amrit Chandan, CEO, oversees the company’s vision and mission He is responsible for developing strategic partnerships with investors and organisations such as the Shell Foundation. With support from the SME Leaders Programme, Dr Chandan aims to build capacity to scale an international team with commercial and technical expertise, while maintaining a company culture that has a focus on strong results and progress.
Visit Aceleron's website here.
Co-Founder and CEO, INSPHERE
INSPHERE develops new measurement technologies for use in advanced manufacturing. Its solutions enable precision measurement and control so that companies can optimise and improve manufacturing performance. This leads to improvements in quality and consistency, greater efficiency and increased profitability.
INSPHERE technologies can be used in environments such as car production lines where failures can lead to costs of up to £10,000 per minute while issues are resolved. The company aims to become a global leader for advanced monitoring and control technologies and already has high-profile customers including Rolls-Royce and the Mercedes Formula 1 team.
Ben Adeline, CEO, is developing a strategy to increase sales of existing products and services while developing new solutions and services. This includes a new product due for launch in late 2020 that will enable continuous monitoring and control of industrial automation systems.
With support and training through the SME Leaders Programme, Ben aims to strengthen his leadership skills in areas such as corporate finance and strategy. This will also help with managing a growing team as the company extends its product range and scales rapidly.
Visit INSPHERE's website here.
Co-founder and Chief Scientific Officer, Sixfold
Sixfold Bioscience has developed a patented technology for the safe and effective drug delivery of cell and gene therapeutics. Its programmable oligonucleotide delivery system (PODS) provides a cost-effective way to deliver a diverse range of therapeutic cargo with high targeting specificity.
There is currently a lack of safe, efficient in vivo delivery systems for cell and gene therapeutics. Many cell and gene therapies show great potential for achieving this, but their wide implementation has been limited by both complex and expensive manufacturing processes, and an inefficiency in reaching their targets. PODS is an efficient, non-viral, RNA-based drug delivery technology that has shown promising early in vitro and in vivo results.
Based at the Translation and Innovation Hub at Imperial College London, Sixfold Bioscience has been awarded funding by Innovate UK to support two projects that will help in accelerating the pre-clinical development of the PODS platform.
Anna Perdix Rosell, Co-founder and Chief Scientific Officer, leads Sixfold Bioscience’s R&D team and is helping to devise its long and short-term strategy for preclinical research. Supported by the SME Leaders Programme, she aims to strengthen skills in strategic product development to support Sixfold’s goal of revenue generation through pharmaceutical collaboration. This will help the company make an impact on the global drug delivery systems market which is currently valued at £/$3.2 billion and is projected to rapidly grow.
Visit Sixfold Bioscience's website here.
CEO, Kalium Health
Kalium Health aims to make it quicker and easier for patients to monitor and manage unstable blood electrolyte levels that can become life-threatening, especially for those with kidney disease. Its first product is a handheld test device for monitoring blood potassium level with clinical accuracy.
The University of Cambridge spin-out is developing the device in response to patients’ request for an alternative to current methods, which involve hospital-based tests requiring a venous blood sample. These are often considered inconvenient, expensive and can lead to delays with treatment. In contrast, Kalium’s device will provide users with real-time results in any setting.
Tom Collings, CEO, is responsible for setting the company’s overall strategy and overseeing operational activities. Supported by the SME Leaders Programme, Tom aims to gain skills in areas such as recruitment, effective leadership and financial management to build a motivated team and drive efficiency as Kalium’s operations rapidly expand.
Networking with peers and support from a mentor will help Tom as he seeks to raise the company’s profile and develop the right commercial partnerships to help Kalium towards its goal to launch its first device in Europe and the US in the next five years.
Visit Kalium Health's website here.
AssetCool aims to improve the efficiency of power networks, and reduce power losses by up to 30%, with a photonic coating for power lines that helps them to manage temperature more effectively.
As electricity lines operate, their heat increases because of incoming solar radiation and the current running through them. This increased heat makes power lines less efficient. AssetCool’s solution is an easy-to-use durable coating for overhead power lines that improves their ability to reflect solar radiation while also allowing infrared heat to escape more easily. This creates extra network capacity by improving conductive efficiency resulting in up to 40% more power down the line and reduced carbon emissions.
Niall Coogan, SME Leader and CEO, is responsible for overseeing developments with the technology, while also focusing on industrial scale up, IP portfolio development and gaining commercial traction in key markets. He aims to use support from the SME Leaders Programme to develop leadership skills that will help with setting a clear strategic vision for a global business.
Training and support in effective management and communication skills will also help Niall to grow his team while directing technological and operational developments as AssetCool scales up to meet service market demand.
Visit AssetCool's website here.
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
David Gammon founded Rockspring in 2002 after 17 years of investment banking experience.
Rockspring provides advice and capital to disruptive technology companies from seed through scale up. His family are the benefactors of the JC Gammon Launchpad Award run by the Enterprise Hub.
David is a non-executive director at Raspberry Pi Trading Limited, Accesso Technology Group plc and Frontier Developments plc.
Suranga has long experience as an engineer and entrepreneur. He founded Blinkx - an intelligent search engine for video and audio content - in 2004. He led Blinkx as CEO for eight years as well as taking it public in 2007. He is widely regarded as an expert on the convergence of the web, television and online advertising.
Before his work with Blinkx, Suranga was US Chief Technology Officer of Autonomy where he was mentored by Mike Lynch and led the effort to enable Autonomy’s software to work in highly distributed environments. Suranga joined Balderton as a General Partner in 2014.
An accomplished speaker and commentator on the overlap between technology and media, Suranga has been elected by the World Economic Forum as one of its Young Global Leaders. He was also included in the Top 10 leaders in Science and Innovation by The Observer’s Future 500 list, and was a recipient of the Royal Academy of Engineering’s Silver Medal in 2012. Suranga was elected a Fellow of the Royal Academy of Engineering (FREng) in 2012.
“The real high-growth value companies are currently all in the tech space. In order for these businesses to reach their potential, it’s vital that they can benefit from the guidance of those with experience.”
Anne is a prominent venture capitalist and European technology investor who has been Chief Executive of Amadeus Capital Partners from 1997. As a co-founder in the organisation, Anne’s role combines her experience as a scientist, operating manager and venture capitalist.
Anne began her career in manufacturing with Cummins Engine Company before moving into investment as a business angel. She was also Chief Operating Officer of Virtuality Group, which had been one of her investee companies.
Anne has held a number of high profile advisory positions, having served as Chairman of the British Venture Capital Association in 2004, and as a non-executive director of the UK Technology Strategy Board from 2005-2012. In 2008 Anne led the establishment of the Glover advisory committee for the Chancellor of the Exchequer, reporting on government procurement from SMEs. She is also a member of the European Research and Innovation Advisory Board. Anne was awarded a CBE for services to business in 2006 and was elected an Honourary Fellow of the Royal Academy of Engineering in 2008.
“There is a long-standing need for science to engage more proactively with policy-makers and business. The Enterprise Hub is playing a big part in addressing this, by bridging the gap between outstanding academic talent and influential figures in the industry to ensure the UK’s ongoing international success in science and technology.”
Chair of the Enterprise Committee and a long-standing Academy Fellow, Ian has played a prominent role in establishing the Enterprise Hub. His track record of helping businesses in the engineering and life science sectors transform their approach and improve their vision, ambition, business models and enterprise value is an invaluable resource.
Ian is currently Managing Director of contract R&D company Arcinova and is also the Managing Partner at investment and advisory firm Shott Trinova LLP. Prior to his specialist investment work at Shott Trinova, Ian was the founder and CEO of Excelsyn, which was sold to an American multinational in 2010. Earlier in his illustrious career he held numerous senior executive positions at multinational life science companies across the globe.
Ian has a wealth of experience with major industry bodies. He is currently the Chair of the UK government’s Leadership Forum for Industrial Biotechnology and a Governing Board Member of Innovate UK. Ian is also Visiting Professor at Oxford, Nottingham and Newcastle Universities.
“Apart from a deep-seated passion to change the entrepreneurial landscape in the UK and rediscover our legacy from the industrial revolution, I am highly excited by the prospect of engaging with new young talent and using my experience to accelerate and amplify their success. I’ve been involved in mentoring for over a decade but believe the Hub offers a very special opportunity to work with the brightest and best”.
Dick Whittington is a serial entrepreneur, business mentor and investor, focusing on the software industry and digital marketplaces, with over thirty years of experience in business. His experience has included co-founding a successful international software business recognised in UK through three Queen's Awards covering both Innovation and International Trade.
In 2012 he was elected Fellow of the Royal Academy of Engineering where he plays an active role including as a mentor for early-stage technology startups and spinouts through its highly successful Enterprise Hub. From 2015 Dick has been Visiting and Honorary Professor of Business Innovation at the University of York, where he has developed and delivered a respected course in Digital Innovation and Entrepreneurship for students and staff. He is also an active mentor and angel investor within several London and regional technology accelerator programmes.
Prior to pursuing business interests, Dick lectured in Computer Science at the University of York. He managed a successful research team and published a number of research papers and books, including Database Systems Engineering (1987), which became a standard text within many universities. He also contributed to several significant texts including The Software Life Cycle (1990) and the Software Engineers' Reference Book (1991).
"The concept of the Enterprise Hub resonated with me as a solid, practical initiative to benefit UK engineering through engaging the Academy’s extraordinary network of talent. The role of the Hub in launching and scaling such businesses is of enormous value to the UK economy and the engineering profession.”
Phil is an active Cambridge-based angel investor where he chairs, coaches, invests in and helps communications, software and device companies. He is a frequent speaker on a broad range of entrepreneurial topics and an advisor to universities on the commercialisation of their IP.
In 1999 Phil co-founded the spin-out Cambridge Silicon Radio (CSR) and as managing director, helped to grow CSR plc from a startup of nine people into a highly successful FTSE 250 listed fabless semiconductor company. In 2003, CSR plc had become the largest global market supplier of Bluetooth chips. By 2015, they had shipped three billion chips, employed more than 2,000 people in 23 locations and was acquired by US-based Qualcomm for $2.5 billion.
Phil has been a research fellow at AERE, a chief research engineer at Standard Telecommunication Laboratories, UK Alvey & CEC ESPRIT project manager and a telecoms practice manager at Arthur D Little’s Cambridge Consultants, from which he spun-out CSR plc.
Phil was a recipient of the MacRobert Award in 2005 along with CSR colleagues, for the world's first high-volume single chip Bluetooth device. He was elected as a Royal Academy of Engineering Fellow in 2017 and holds an honorary doctorate from the University of Essex.
“I believe that the commercialisation of IP and the engineering of high-volume products is integral to a vibrant and healthy society. The Enterprise Hub has created an effective mechanism for enabling Fellows to become coaches and mentors to the next generation of engineering entrepreneurs and I am honoured to be in a position to help contribute to its success.”
Formerly the UK Innovation Director for Atkins, Elspeth is the CEO and Founder of IAND, a digital platform that helps major enterprises manage multiple suppliers.
Initially graduating as a chemist, Elspeth later turned her hand to transport and urban design, demonstrating business and technical leadership on over 100 transport planning projects both nationally and around the world.
Elspeth chairs the Enterprise Hub’s Innovators Network and is a judge for the Hub’s Launchpad Competition. She is also a member of the Royal Academy of Engineering’s Diversity and Inclusion Committee.
In 2017, Elspeth was awarded a Member of the Order of the British Empire (MBE) for her services to Engineering and Enterprise.
“I believe that collaboration within our industry is the key to driving innovation faster. I am so proud to be involved with the Enterprise Hub, as a Mentor, and as Chair of the Innovators Network and to support young entrepreneurs as a Judge on Launchpad competition.
It is rare to find a place which brings together startups and established companies to exchange ideas and learn from each other. We have a shared goal which is to fast track the growth of engineering enterprises in the UK. The Enterprise Hub has helped me grow my business and it is helping young engineers build the businesses of the future.”
Nigel’s career has involved working in the UK and the Netherlands for Unilever and Wellcome Research. While abroad, he built and operated the first large-scale Dutch facility for the manufacture of the genetically engineered protein alpha-galactosidase. Later, he led the process design for Wellcome’s WelGen interferon manufacturing plant in the USA.
Nigel has served as a co-founding non-executive director for two manufacturing SMEs, Cobra Biomanufacturing Plc (which was listed on AIM) and Angel Technology Ltd. The latter was awarded the Queen’s Award for Innovation in 2006 and the International Sial d’Or prize for the most innovative new UK nutritional product at the Paris International Food Conference 2004. Currently he is Head of the Department of Chemical Engineering and Biotechnology at Cambridge University.
Nigel was elected a Fellow of the Royal Academy of Engineering (FREng) in 2004.
“My relevant technical and personal experience was well-matched to Janice’s needs and I am pleased to be involved in such a positive initiative.”
Saeed is Technical Director at the prosthetic manufacturer Blatchford, winners of the 2016 RAEng MacRobert Award.
He has built a highly successful career based on outstanding innovation, product development and scientific research in the field of prosthetics. His work saw the company shortlisted for the Royal Academy of Engineering MacRobert Award in 2010.
Saeed has provided invaluable advice to emerging innovators in his field, such as negotiating with investors, creating new business cases and establishing alternative investment return strategies, IP issues, and how to identify new needs and opportunities in the market to develop a road map of future products.
He was elected a Fellow of the Royal Academy of Engineering (FREng) in 2012.